Chief Executive Officer
Jonathan Adam Barash is an accomplished Chief Executive Officer with 25 years of global experience as an entrepreneur and executive leader. Throughout his career, he has demonstrated exceptional ability in…
Research Group – Fluorescent lateral flow tests
A team of researchers led by scientists that has developed fluorescent lateral flow test (FLFT) for our early detection cancer rapid tests. A fluorescent lateral flow test (FLFT) is a…
Board Member – name pending
A distinguished member of a Scientific Advisory Council, which has made significant contributions to cancer immunotherapy, particularly in ovarian cancer. His research focuses on identifying tumor antigens and developing immunotherapeutic…
Leading Professor of Pathology – Cancer Warrior
AbulKalam M. Shamsuddin, M.B.,B.S., Ph.D., served as Professor of Pathology at the University of Maryland School of Medicine in Baltimore, MD, for over 43 years, Senior Scientist at National Cancer…